Skip to main content

Table 1 Age- and gender-specific seroprevalence of HSV-1 and HSV-2 among rural residents in Eastern China

From: Herpes simplex virus infections among rural residents in eastern China

 

Male (n = 1065)

Female (n = 1076)

Total (n = 2141)

   

HSV-1

HSV-2

  

HSV-1

HSV-2

  

HSV-1

HSV-2

Age (years)

Tested/Eligible

%*

%** (95% CI)

%** (95% CI)

Tested/Eligible

%*

%** (95% CI)

%** (95% CI)

Tested/Eligible

%*

%** (95% CI)

%** (95% CI)

5-

75/106

70.8

59.8 (20.9-98.8)

0

40/54

74.1

64.9 (46.4-83.5)

0

115/160

71.9

61.6 (27.3-95.8)

0

10-

64/84

76.2

78.0 (47.6-100.0)

0

45/74

60.8

78.3 (37.8-100.0)

0

109/158

69.0

78.1 (75.2-81.1)

0

15-

89/109

81.7

76.5 (68.9-84.0)

5.4 (0-33.5)

78/97

80.4

87.5 (20.0-100.0)

8.9 (0-18.6)

167/206

81.1

81.6 (48.4-100.0)

7.1 (0-19.2)

20-

93/120

77.5

81.9 (43.2-100.0)

8.9 (0-64.1)

101/121

83.5

86.1 (64.5-100.0)

12.0 (0-48.7)

194/241

80.5

84.0 (78.0-90.0)

10.5 (0-54.5)

25-

112/134

83.6

86.5 (64.5-100.0)

5.3 (0-14.6)

135/155

87.1

93.3 (58.3-100.0)

13.3 (0-37.0)

247/289

85.5

90.3 (58.3-100.0)

9.7 (0-30.2)

30-

137/157

87.3

90.4 (72.2-100.0)

10.2 (2.4-18.0)

152/182

83.5

96.7 (94.7-100.0)

13.1 (5.0-21.3)

289/339

85.3

93.8 (82.3-100.0)

11.8 (11.5-12.0)

35-

144/163

88.3

93.7 (85.2-100.0)

13.8 (0-34.6)

154/182

84.6

95.5 (81.4-100.0)

16.2 (0-77.7)

298/345

86.4

94.6 (82.8-100.0)

15.1 (0-57.7)

40-

118129

91.5

97.4 (89.6-100.0)

13.6 (6.8-20.4)

129/153

84.3

98.4 (97.7-99.2)

17.8 (0-38.2)

247/282

87.6

98.0 (94.5-100.0)

15.9 (2.7-29.0)

45-

89/113

78.8

96.7 (60.5-100.0)

23.7 (0-100.0)

97/114

85.1

98.0 (76.9-100.0)

24.9 (0-60.5)

186/227

81.9

97.4 (68.7-100.0)

24.3 (0-84.8)

50-

82/106

77.4

98.7 (87.7-100.0)

8.5 (0-52.1)

101/120

84.2

98.1 (69.7-100.0)

16.1 (0-80.7)

183/226

81.0

98.4 (88.4-100.0)

12.5 (0.3-24.8)

55-

62/71

87.3

98.4 (76.2-100.0)

16.1 (4.7-37.0)

44/56

78.6

97.8 (71.8-100.0)

16.1 (0-63.0)

106/127

83.5

98.1 (97.1-99.1)

16.1 (7.1-25.2)

Total

1065/1292

82.4

89.1 (70.0-100.0)

10.5 (10.4-10.5)

1076/1308

82.3

94.2 (94.0-94.5)

15.3 (0-33.3)

2141/2600

82.3

92.0 (84.2-99.8)

13.2 (3.6-22.7)

  1. *: participation rate; **: seroprevalence